Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Vorinostat × 30 days × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Recurrence 1 Oligodendroglioma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 GATA2 Deficiency 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Anemia, Refractory 1

Interventions

Cisplatin 4 Platinum 3 Pemetrexed 3 1,2-diaminocyclohexaneplatinum II citrate 3 pembrolizumab 2 tremelimumab 1 methoxyamine 1 decitabine and cedazuridine drug combination 1 cediranib 1 atezolizumab 1 aldesleukin 1 Radiotherapy 1 Radiation 1 Pharmaceutical Preparations 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1 Cyclophosphamide 1 Carboplatin 1 Bevacizumab 1 BAY 1895344 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡